The DMBA/TPA treatment protocol was applied to the back skin in cohorts of 63 tamoxifen-treated K14CRE-ERT2-STIL+/- females and 32 oil-treated K14CRE-ERT2-STIL+/- female control mice, and tumor development was followed over time. The gene discussed is MAPK3; the disease is neoplasm.